Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | FBLG FibroBiologics, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $1.43 -3.7% | $15.06 -2.0% |
| StockIQ Score | 43D Weak Risk: High | 36F Weak Risk: Medium |
| Technical | 41D | 13F |
| Fundamental | 41D | 35F |
| Growth | 32F | 50C- |
| Fair Value | 38F | 38F |
| News | 80A- | 50C- |
| Quality | — | 50C- |
| Risk | 40D | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
FibroBiologics (FBLG) outperforms Ascentage Pharma (AAPG) in technical and investor scores, with 92 versus 18 and 56 versus 37, respectively. AAPG leads in growth, scoring 50 compared to FBLG’s 32. Both share the same valuation score of 38, but FBLG’s moderate rating contrasts with AAPG’s weak classification.
